Fosfomycin susceptibility among multidrug resistant and extended spectrum β-lactamase producing uropathogenic Escherichia coli isolates at a tertiary care hospital …
R Jain, N Pal, S Hooja - CHRISMED Journal of Health and …, 2022 - journals.lww.com
Fosfomycin Susceptibility among Multidrug Resistant and Exte... : CHRISMED Journal of Health
and Research Fosfomycin Susceptibility among Multidrug Resistant and Extended Spectrum …
and Research Fosfomycin Susceptibility among Multidrug Resistant and Extended Spectrum …
[PDF][PDF] Increasing antibiotic resistance in uropathogenic Escherichia coli: Is Fosfomycin a promising alternative?
P Singla, J Sangwan, P Singh, P Mane, K Yadav… - Surgery - researchgate.net
Background: Antimicrobial resistance in uropathogenic Escherichia coli is encountered
increasingly now a days. Fosfomycin has emerged as a promising solution for clinicians to …
increasingly now a days. Fosfomycin has emerged as a promising solution for clinicians to …
Evaluation of in Vitro Activity of Fosfomycin Against Uropathgens of Enterobacteriaceae Isolates in the Era of Multidrug Resistance
P Peshattiwar, H Joshi, S Mishra, P Khanorkar… - demo.makhillpublications.co
The commonly isolated uropathogen are increasingly showing multidrug resistance against
routinely used antimicrobial agents and limited therapeutic options for clinicians …
routinely used antimicrobial agents and limited therapeutic options for clinicians …
[PDF][PDF] Pragati khanorkar and Rashmi Bhardwaj, 2022. Evaluation of in Vitro Activity of Fosfomycin Against Uropathgens of Enterobacteriaceae Isolates in the Era of …
P Peshattiwar, H Joshi, S Mishra - Res. J. Med. Sci, 2022 - demo.makhillpublications.co
The commonly isolated uropathogen are increasingly showing multidrug resistance against
routinely used antimicrobial agents and limited therapeutic options for clinicians …
routinely used antimicrobial agents and limited therapeutic options for clinicians …